Navigation Links
New study says probiotic use for infant colic is not effective in reducing symptoms
Date:4/17/2014

CHICAGO, IL, April 17, 2014-- Colic affects about one in five infants in the United States annually and accounts for numerous pediatric visits during the first several months after birth. Research into probiotic use for reduction of colic symptoms was showing promise; however, the April 1, 2014 issue of the British Medical Journal (BMJ2014;348:g2107; Sung, Valerie) reported on a study, "Probiotics and Infant Colic," concluding that the use of the probiotic L reuteri for infant colic did not reduce crying or fussing in infants nor was it effective in improving infant sleep, functioning or quality of life. The results were no different for babies receiving breast milk or formula.

"The role of different intestinal microbes in producing or alleviating colic remains a subject of interest," says Joel Lavine, M.D., Ph.D., professor of pediatrics and chief of pediatric gastroenterology, hepatology and nutrition at Columbia University Medical Center. "Some studies have identified changes in the colonization that are associated with colic, although these changes have not been shown to be causative, and the specific kinds of bacteria potentially responsible have not been identified. Thus far, manipulation of gut colonization by probiotics remains an inexact science and conflicting evidence exists regarding the efficacy of probiotics in improving the problem."

Another under-discussed cause of colic symptoms, transient lactase deficiency (TLD), is known to be a cause of colic in about 38% of cases*. TLD is a temporary insufficiency of lactase enzyme, resulting in temporary digestive discomfort caused by the undigested lactose in breast milk or infant formula, often resulting in excessive crying and fussing, otherwise known as colic.

"Manipulation of bacterial populations in the gut may reduce the amount of gas produced by virtue of reducing lactose malabsorption," adds Dr. Lavine. "This problem of lactose malabsorption can be easily resolved by providing lactase to infants who are lacking, by way of commercially available infant drops."


'/>"/>

Contact: Danielle Maiello
dmaiello@rlapr.com
914-241-0086
Robin Leedy & Associates, Inc.
Source:Eurekalert

Related medicine news :

1. Study IDs new cause of brain bleeding immediately after stroke
2. Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum
3. Celldexs Phase 1 study of CDX-1401 published in Science Translational Medicine
4. Study links severe sleep apnea to increased risk of stroke, cancer and death
5. Kessler Foundation scientists receive Biogen Idec grant to study actual reality in MS
6. UT Dallas study: Youth who fail to envision future commit more crimes
7. Study identifies a likely key driver of colorectal cancer development and progression
8. Study gives high marks to NC Pre-K program
9. Proteomics International biomarker study closer to a CDx test for diabetic kidney disease
10. Study links domestic abuse to mental health problems in new mothers
11. Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., ... for adherence to the highest standards of trauma, maternity, cancer and chronic obstructive ... president and CEO, Dr. Daniel Messina. , Among the recognitions, the American College ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
(Date:12/8/2016)... Rock, AR (PRWEB) , ... December 08, 2016 ... ... providing insurance and financial planning services from offices headquartered in Little Rock, has ... Food Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey ... to residential and commercial clients in the northern Alabama and Georgia regions, is ... , Since 1977, Nobis Works has built a network of support and education ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX , ... Nationwide Children,s Hospital signed a membership agreement ... the development of new cures. The ... over 57 million patients globally, biopharmaceutical companies and ... to improve protocol design, site selection, patient recruitment, ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: